Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
about
Models of chronic obstructive pulmonary diseaseLinking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cellsAerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery SystemsThe role of CLCA proteins in inflammatory airway diseaseEmbryonic chicken trachea as a new in vitro model for the investigation of mucociliary particle clearance in the airwaysMolecular mechanisms of pulmonary peptidomimetic drug and peptide transport.Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells.Analysing the causes of chronic cough: relation to diesel exhaust, ozone, nitrogen oxides, sulphur oxides and other environmental factorsAnalysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).Antibody to mCLCA3 suppresses symptoms in a mouse model of asthma.Mucin production during prenatal and postnatal murine lung development.Mucous solids and liquid secretion by airways: studies with normal pig, cystic fibrosis human, and non-cystic fibrosis human bronchi.Chronic continuous positive airway pressure (CPAP) reduces airway reactivity in vivo in an allergen-induced rabbit model of asthma.Asthma deaths; persistent and preventable mortality.Copy number variation burden on asthma subgenome in normal cohorts identifies susceptibility markers.Expression of ErbB receptors and mucins in the airways of long term current smokers.Distinctive epidermal growth factor receptor/extracellular regulated kinase-independent and -dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by phorbol 12-myristate 13-acetate.Analysis and evaluation of environmental tobacco smoke exposure as a risk factor for chronic cough.Neurogenic mechanisms in bronchial inflammatory diseases.Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationMUC5B expression and location in surfactant protein C mutations in children.Regulation of airway mucin gene expressionEvaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.Airway mucus: From production to secretion.Treatment of airway mucus hypersecretion.Glucocorticoid receptor and histone deacetylase-2 mediate dexamethasone-induced repression of MUC5AC gene expression.The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.MUC5B Is the predominant mucin glycoprotein in chronic otitis media fluid.Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study.Fibrinogen binding to ICAM-1 promotes EGFR-dependent mucin production in human airway epithelial cells.RNAi Therapeutic Platforms for Lung Diseases.Magnetic Nanodrug Delivery Through the Mucus Layer of Air-Liquid Interface Cultured Primary Normal Human Tracheobronchial Epithelial Cells.Reconstruction is not renovation - the role of remodeling in asthma.Role of transcription factors in the pathogenesis of asthma and COPD.Inhalation therapy to treat pulmonary arterial hypertension.Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models.MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma.Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.Montelukast prevents antigen-induced mucociliary dysfunction in sheep.MUC5B promoter polymorphisms and risk of coal workers' pneumoconiosis in a Chinese population.
P2860
Q24798450-8AA36759-C67E-40F9-B39F-8366CF804370Q26827549-10843D06-D5E9-4DF4-9A8D-A8932E0EE8B6Q28392004-92C041D1-8A93-4E04-9AE8-CB351ACA6F3AQ28657590-159A9B7F-A5C5-4970-883A-E717AEFB61D8Q30497327-D771CE60-619C-45B6-A83B-5894E6867143Q33198362-EF68A636-8D3F-4E0E-9DD5-F8E5EE43FF5DQ34554622-458FC903-8B97-421C-8AA7-BCF9A0F22154Q34899103-11FD513E-68CF-4C61-BC88-57B6D1278DAEQ35016089-8B1ACEBE-5DD6-4FDA-B31C-E0DE160D789EQ35070224-9B1DA805-6648-4F3B-A511-545173267ED3Q35103876-A04C4610-3B42-4981-9839-41F533A40CCAQ35159743-224B6C97-2DEE-4E8C-A776-BB9FA76F7370Q35160008-19012242-E009-4256-8D7B-1EB901EA6C9BQ35183809-9E177E33-B38F-4E31-BF58-92465D61841DQ35420597-B265CEB6-874F-4460-8226-698DB1F96AF9Q35536390-80727C3C-31F1-48C6-9AF8-9AA58A40F524Q35570361-4B9A1315-8077-41E3-8F8A-93766B64E9D3Q35825110-ADBAFC06-6E71-415D-A65D-D44E53549F1DQ35907064-4596A7D1-2156-412E-83F9-5FDF52C46898Q36062727-0CEBB7DA-755B-46DE-A98A-FBE6D42C7B37Q36132579-B235BB82-C85C-4DF4-AB3F-77362482292BQ36216587-787DEFA1-1A8A-45F8-99D9-ABC5B13F6C19Q36270342-F7B34B77-B4DA-4C42-8905-FE5E2F7C075CQ36369409-1641BA17-6DF8-4733-9482-5E676D4E3C9EQ36438219-34AEB09D-ACD5-4FC3-9857-78250F85CD4FQ36539631-AF65A884-E056-4CC6-86CD-9F0743BF3D04Q36674100-53A73A94-21E5-457E-B65E-9156A94F9477Q36919911-855172ED-716A-4EBE-B2A7-9F2110E33B24Q37150785-48BB555A-4102-4093-92B4-35507BE1CF28Q37264762-EBC01018-DD6A-49A8-A4F2-F78F68DCCC72Q37277373-E1A9146B-B774-4075-A45B-0591A3FA3E60Q37350756-4D15D2DC-7DFE-4932-AA93-77E23E328027Q37857701-761EBEDD-E995-45E3-B7DC-22730E6BAA87Q38087650-6542E055-41DE-45C2-9BEC-93C48589CB16Q38162947-B3D63276-9509-4FC2-B1F3-9EE87E822727Q38637937-DCFC5899-32BF-4331-9ED3-F2C65D763FD1Q40131321-071EA489-273A-48AC-86D6-5B99D6D9490DQ43177938-041A4A19-DC35-4869-BB10-8048AFAC867FQ44198459-EC5ADF18-4D47-42B1-AD0F-246F4094B875Q44615266-391E5110-7BD3-4583-9E16-95A2F9420973
P2860
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@en
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@nl
type
label
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@en
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@nl
prefLabel
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@en
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@nl
P2093
P2860
P1433
P1476
Expression of respiratory mucins in fatal status asthmaticus and mild asthma.
@en
P2093
Carlstedt I
Harrison BD
Nicholson AG
P2860
P304
P356
10.1046/J.1365-2559.2002.01378.X
P577
2002-04-01T00:00:00Z